ASLAN PHARMACEUTICALS LT-ADR (ASLN)

US04522R2004 - ADR

0.51  +0.07 (+15.91%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.003.00M0.00
Minority Interest Expense
0.00270.00K770.00K50.00K0.00
Cost Of Goods
N/A0.000.00410.00K0.00
Gross Profit
N/A0.000.002.59M0.00
Operating Expenses
47.88M33.85M16.48M25.10M42.35M
Research and Development
38.00M22.02M9.31M16.59M31.83M
Selling, General, and Administrative Expenses
9.88M11.83M7.17M8.51M10.51M
Operating Income
-47.88M-33.85M-16.48M-22.51M-42.35M
Interest Income/Expense
-3.71M-1.16M-1.38M-930.00K-70.00K
Other Income/Expense
278.97K1.08M760.00K-70.00K240.00K
Non Recurring Items
29.15K2.34M130.00K-23.07M0.00
Income Before Taxes
-51.28M-31.59M-16.97M-46.66M-42.17M
Income Tax
99.22K0.000.00410.00K10.00K
Net Income
-51.38M-31.32M-16.20M-47.02M-42.19M
EBITDA
-47.55M-33.57M-16.18M-22.07M-42.10M
 
Per Share Data
EPS Diluted Total Ops
-14.00-9.12-7.98-27.56-26.80
Non GAAP EPS
-3.74-1.12-0.45-1.43-1.38
 
Statistics
Gross Profit Margin
N/AN/AN/A86.33%N/A
Profit Margin
N/AN/AN/A-1567.33%N/A
Operating Profit Margin
N/AN/AN/A-750.33%N/A

All data in USD

Charts